HealthEquity Reports Second Quarter Ended July 31, 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
HealthEquity (HQY) Tops Q2 EPS by 10c, Offers FY Guidance
September 3, 2019 4:06 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.45, $0.10 better than the analyst estimate of $0.35. Revenue for the quarter came in at $86.6 million versus the consensus estimate of $85.32 million.
GUIDANCE:
HealthEquity sees FY2020 revenue of $341-347 million, versus the consensus of $343.3 million.
We have updated the HealthEquity standalone outlook for the year ending January 31, 2020. We expect our revenue to be between $341 million and $347... More